Grifols shifts toward value diagnosticsBy Ion Jauregui – Analyst at ActivTrades
Strategic break with QuidelOrtho and new stage in diagnostics
The Spanish company Grifols has ended its more than four-decade alliance with QuidelOrtho for the production of antigens, in a move that marks a turning point in its diagnostics strategy. As p
Grifols, S.A. Class A
No trades
No trades
Compare with Grifols, S.A. Class A
0.665 EUR
402.00 M EUR
7.52 B EUR
265.28 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Details
Sector
Industry
CEO
Jose Ignacio Abia Buenache
Website
Headquarters
Barcelona
Founded
1909
IPO date
Jun 5, 2006
ISIN
ES0171996087
FIGI
BBG000KXRSZ5
Identifiers
ISIN ES0171996087
Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma for therapeutic use. The Hospital division offers non-biological pharmaceutical products and medical supplies for hospital pharmacy. The Diagnostic division provides clinical analysis and laboratory testing tools to laboratories, hospitals and blood banks. The Raw materials division includes sales of intermediate biological products, as well as manufacturing services to third parties. The Company operates production facilities in Spain, the United States, Mexico and Australia, among others. It controls numerous subsidiaries.
Buy $GRFS - NRPicks 11 MarGrifols, S.A. engages in the acquisition, manufacture, preparation and sale of therapeutic products, principally plasma derivatives. The company operates through the Bioscience, Hospital, Diagnostics, Bio Supplies and Others segments.
Revenue TTM 5.6B
Net Income TTM 208M
EBITDA TTM 894M
EBITDA mar
Are we at the bottom yet?Grifols stock has been heavely punished during 2021.
First the pandemic difficulted the plasma collection. We must take into account the stimulus checks and the unemployment benefits from the US goverment wich might have disuaded people from going to the plasma collection centers to get some extra
GRIFOLS: Throw-back becoming a reality?After surpassing Fib 0.5, it looks like the stock is heading towards 0.382 level (21.81). Right now the company is immersed in a share repurchase program since 12/03/2021 and it has already acquired 19.23% of its €125 million valued shares objective. Maybe the company's financial advisers are playin
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateOct 15, 2028
Coupon4.75% (Fixed)
Maturity dateOct 15, 2028
Coupon3.88% (Fixed)
See all GRF bonds
Frequently asked questions
The current price of GRF is 10.150 EUR — it has increased by 0.74% in the past 24 hours. Watch Grifols, S.A. Class A stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BME exchange Grifols, S.A. Class A stocks are traded under the ticker GRF.
GRF stock has fallen by −0.78% compared to the previous week, the month change is a 14.56% rise, over the last year Grifols, S.A. Class A has showed a −18.93% decrease.
We've gathered analysts' opinions on Grifols, S.A. Class A future price: according to them, GRF price has a max estimate of 23.00 EUR and a min estimate of 9.00 EUR. Watch GRF chart and read a more detailed Grifols, S.A. Class A stock forecast: see what analysts think of Grifols, S.A. Class A and suggest that you do with its stocks.
GRF stock is 0.89% volatile and has beta coefficient of 0.79. Track Grifols, S.A. Class A stock price on the chart and check out the list of the most volatile stocks — is Grifols, S.A. Class A there?
Today Grifols, S.A. Class A has the market capitalization of 6.86 B, it has increased by 1.89% over the last week.
Yes, you can track Grifols, S.A. Class A financials in yearly and quarterly reports right on TradingView.
Grifols, S.A. Class A is going to release the next earnings report on Nov 10, 2026. Keep track of upcoming events with our Earnings Calendar.
Grifols, S.A. Class A revenue for the last quarter amounts to 1.87 B EUR, despite the estimated figure of 1.89 B EUR. In the next quarter, revenue is expected to reach 1.97 B EUR.
GRF net income for the last quarter is 154.00 M EUR, while the quarter before that showed 73.00 M EUR of net income which accounts for 0.00% change. Track more Grifols, S.A. Class A financial stats to get the full picture.
Grifols, S.A. Class A dividend yield was 1.76% in 2025, and payout ratio reached 31.87%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 13, 2026, the company has 25.26 K employees. See our rating of the largest employees — is Grifols, S.A. Class A on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Grifols, S.A. Class A EBITDA is 1.65 B EUR, and current EBITDA margin is 22.41%. See more stats in Grifols, S.A. Class A financial statements.
Like other stocks, GRF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Grifols, S.A. Class A stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Grifols, S.A. Class A technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Grifols, S.A. Class A stock shows the neutral signal. See more of Grifols, S.A. Class A technicals for a more comprehensive analysis.









